Marketresearch.biz reports that Thyroid Gland Disorder Treatment market is expected to index a valuation of $3,105.7 million ...

IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 18, 2024 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), ...

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESCALGARY, AB / ACCESSWIRE / April 17, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) ...

Annual Reportaap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages17-Apr-2024 / 18:57 CET/CESTDisclosure of an inside information acc. to ...

CEOsHAYWARD, CA / ACCESSWIRE / April 17, 2024 / Accuryn Medical, innovator of the Accuryn Monitoring System, a device designed to monitor the kidney, reduce the risks associated with ...

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of new preclinical data in the highly reputable scientific journal Cell Reports on the clinical stage antibody CAN10, ...

According to a recent report by Market.us, the Global Cell Dissociation Market size is expected to be worth around USD 1,141.2 Million by 2032 from USD 382.7 Million in 2023, growing at a CAGR of 13.3 ...

According to Market.us, the Face Mask Machine Market is projected to reach approximately USD 27.4 billion by 2032, showing significant growth from USD 11.7 billion in 2022. This expansion is expected ...

Rob Brown, Chief Growth Officer, PharmaCord JEFFERSONVILLE, Ind., April 17, 2024 (Newswire.com) - PharmaCord LLC, a leading provider of patient support services for the pharmaceutical industry, is ...

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on .The Company is ...

Technology offers timely and cost-efficient infection prevention solution for long-term care amidst industry-wide labor shortagesDALLAS, TX / ACCESSWIRE / April 17, 2024 / Today, ActivePure ...